California Cancer Reporting System Standards, Volume III
CoC
California Hospital Transmit
Eureka Admission Level
Eureka Tumor Level
TNM Clin T [NAACCR #940]
TNM Clin N [NAACCR #950]
TNM Clin M [NAACCR #960]
TNM Clin Stage Group [NAACCR #970]
Primary Site [NAACCR #400]
Histologic Type ICD-O-3 [NAACCR #522]
Behavior Code ICD-O-3 [NAACCR# 523]
Date of Diagnosis [NAACCR #390]
TNM Edition Number [NAACCR #1060]
Age at Diagnosis [NAACCR #230]
Grade [NAACCR #440]
CS Site-Specific Factor 5 [NAACCR #2920]
CS Site-Specific Factor 6 [NAACCR #2930]
CS Site-Specific Factor 10 [NAACCR #2864]
CS Site-Specific Factor 11 [NAACCR #2865]
CS Site-Specific Factor 25 [NAACCR #2879]
Sex [NAACCR #220]
Type of Reporting Source [NAACCR# 500]
AC7G2016.DBF
CLST7VAL.DBF
IF1165: Inconsistency between TNM categories T [value] N [value] M [value] and assigned TNM stage [value]
IF1165: Combination of T [value] N [value] M [value] is invalid for TNM staging
IF1165: T [value] N [value] M [value], staging parameter for [value], inconsistent with TNM stage [value]
IF1165: Combination T [value] N [value] M [value], staging parameter for [value], invalid for TNM staging
This edit is skipped if any of the following conditions are true:
Year of Date of Diagnosis is less than 2016, blank (unknown), or invalid
Type of Reporting Source = 7 (Death Certificate Only)
Histologic Type ICD-O-3 is blank
Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
TNM Edition Number is not = 07, U7, and not = 88
TNM Clin Stage Group is blank
TNM Clin T, TNM Clin N, or TNM Clin M is blank
The purpose of this edit is to validate the coded TNM categories, and site-specific staging parameters where used, with the coded Stage Group assignments. The edit is used for site/histology groups in AJCC 7th Edition chapters 3 through 28. Some TNM chapters require elements in addition to T, N, and M categories, such as grade or mitotic rate. for correct stage assignment. In this edit description, these elements are called staging parameters. The edit will not be skipped but will pass if a required staging parameter is blank.
The edit compares the combination of TNM Clin T, TNM Clin N, TNM Clin M categories, and staging parameter where required, with TNM Clin Stage Group.
The designation of "c" or "p" within the individual T, N, and M codes is ignored for this edit. Valid codes for individual fields (TNM Clin T, TNM Clin N, TNM Clin M, TNM Clin Stage Group), and for these individual fields by primary site, are checked in other edits.
An edit failure is returned if the Clin Stage Group is inconsistent with the expected group assignment for the coded T, N, M, and staging parameter if required, based on the AJCC stage tables. If a T, N, or M value is coded that is not included in the AJCC stage tables -- for example T4 is coded but only T4A and T4B are staged -- the stage assignment will not be checked and the edit will pass.
An edit failure is also returned if either the coded Clin Stage Group or the coded Path Stage Group returns "ERROR" from the lookup table, meaning that the combination of T, N, M, and staging parameter is invalid. Invalid combinations include T0N0M0/M0I+; T in situ with positive N and/or positive M category; and a Testis stage with an invalid S category. An invalid S category results when one or more of the 3 site-specific factors required to determine the category (SSF 13-AFP, SSF 15-hCG, SSF 16-LDH) is coded 988, meaning not applicable.
The site/histology groups are listed below. The number next to each site title indicates the respective chapter in the AJCC Cancer Staging Manual, Edition 7.The site/histology groups and group stage values are identified by site and histology in the edit Primary Site, Stage Group 2016 - Ed 7. Subdivisions of some groups were required for this edit; they are identified below with their criteria. Site-specific staging parameters are also identified. The description does not include the list of TNM categories, staging parameters, and stage groups; this information is contained in a table within EditWriter that contains around 14,000 records
Lip and Oral Cavity
Pharynx
4A.Oropharynx and Hypopharynx
4B.Nasopharynx
4C. Nasopharynx
4D. Oropharynx - Pharyngeal
Tonsil
Larynx
5A. Supraglottis, Subglottis, Other
5B. Glottis
Nasal Cavity and Paranasal Sinuses
Major Salivary Glands
Thyroid Gland
8A. Thyroid: Papillary/follicular, age less than 045
8B. Thyroid: Papillary/follicular, age greater than or equal 045 but not 999
8C. Thyroid: Papillary/follicular, age equal 999 (unknown)
8D. Thyroid: Medullary
8E. Thyroid: Anaplastic
8F. Thyroid: Anaplastic
Mucosal Melanoma of the Head and
Neck
Esophagus and Esophagus Gastric Junction
10A. Esophagus
Division for Staging:
10C. Esophagus Adenocarcinoma
Histologies: 8050, 8140-8147, 8160-8162, 8170-8175, 8180-8221, 8250-8507,
8514-8551,8571-8574, 8576, 8940-8941
10D. Esophagus Squamous
Cell Carcinoma
Histologies: 8000-8046, 8051-8131, 8148-8157, 8230-8249, 8508, 8510-8513,
8560-8570, 8575, 8905, 8980-8981
Sites and TNM not included in 10E, 10H
10E. Esophagus Squamous
Cell Carcinoma
Site, TNM: C150, C151, C153, C154
cT2cN0cM0, cT3cN0cM0
10H. Esophagus Squamous
Cell Carcinoma
Site, TNM: C152, C155, C158, C159
cT2cN0cM0, cT3cN0cM0
Staging Parameter: Grade
10B. Esophagus Gastric Junction
Division for Staging:
10F. Esophagus Gastric
Junction Adenocarcinoma
Histologies: 8050, 8140-8147, 8160-8162, 8170-8175, 8180-8221, 8250-8507,
8514-8551,8571-8574, 8576, 8940-8941
10G. Esophagus Gastric
Junction Squamous Cell Carcinoma
Histologies: 8000-8046, 8051-8131, 8148-8157, 8230-8249, 8508, 8510-8513,
8560-8570, 8575, 8905, 8980-8981
Staging Parameter: Grade
Stomach
Small Intestine
Appendix
13A. Appendix: Carcinoma
Staging Parameter: Grade for mucinous and non-mucinous tumors, as collected in CS SSF 11
13B. Appendix: Carcinoid
Colon and Rectum
Anus
Gastrointestinal Stromal Tumor (GIST)
16A. GIST: Gastric
Staging Parameter: Mitotic Count, as collected in CS SSF 6 for GIST Stomach, CS SSF 5 for GIST Omentum
16B. GIST: Small Intestine
Staging Parameter: Mitotic Count, as collected
in CS SSF 6 for GIST Esophagus, CS SSF 11 for GIST
Small Intestine, GIST Colon and Rectum, CS SSF 5 for GIST Mesentery
Neuroendocrine Tumors (NET)
17A. NET: Stomach
17B. NET: Small Intestine and Ampulla of Vater
17C. NET: Colon and Rectum
Liver
Intrahepatic Bile Ducts
Gallbladder
Perihilar Bile Ducts
Distal Bile Duct
Ampulla of Vater
Exocrine and Endocrine Pancreas
Lung
Pleural Mesothelioma
Bone
Division for Staging:
27A. Bone Non-Ewing
Histologies: 8800-9136, 9142-9252, 9261-9363, 9365-9582
Staging Parameter: Grade, for Non-Ewing
27B. Bone Ewing
Histologies: 9260, 9364
Soft Tissue Sarcoma (not edited)
Staging Parameter: Grade
08/2016 |
Per NAACCR v16, new edit added. |
09/2016 |
Per NAACCR v16A:
|
11/2016 |
Per NAACCR v16B:
|
03/2017 |
Per NAACCR v16D:
|